clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01551368 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | Canada | Q16 |
P582 | end time | 2014-04-01 | |
P4135 | maximum age | 40 | |
P1050 | medical condition | infertility | Q179399 |
P2899 | minimum age | 25 | |
P1132 | number of participants | 12 | |
P4844 | research intervention | calcium oxalate | Q412399 |
P1813 | short name | nimodipine | |
P580 | start time | 2012-12-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Using Nimodipine, a Calcium Channel Blocker, to Prevent the LH Surge and Ovulation in Women Undergoing Assisted Reproduction |